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>60 years of age (8). Those fi ndings 
suggest that A. schaalii is a common 
undetected pathogen, especially in el-
derly patients with unexplained chron-
ic UTI.
We report infective endocarditis 
caused by A. schaalii. To our knowl-
edge, infective endocarditis caused by 
Actinobaculum spp. has not been re-
ported. However, several reports have 
documented endocarditis caused by 
Arcanobacterium spp. and Actinomy-
ces spp., which are phylogenetically 
related to Actinobaculum spp. (10).
Characteristics of the patient 
reported here differed from those of 
patients in previous reports. He had 
no underlying urologic condition and 
could not recall any symptoms usu-
ally associated with UTI during the 
year before hospital admission. Urine 
culture remained negative for Acti-
nobaculum spp. despite prolonged 
incubation for 5 days on chocolate 
agar in an atmosphere of 5% CO2 and 
on Schaedler agar under anaerobic 
conditions.
This report highlights the use-
fulness of the recent development of 
a specifi c real-time PCR by Bank et 
al. (7), which may prove effective not 
only for patients typically at risk for 
A. schaalii but also for patients with 
a wider spectrum of infection. More 
studies are needed to identify the real 
prevalence of disease caused by this 
diffi cult-to-cultivate organism because 
it may occur in many other groups of 
patients.
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Mycobacterium 
chelonae Wound 
Infection after 
Liposuction
To the Editor: We recently inves-
tigated a case of Mycobacterium che-
lonae abdominal wound infection af-
ter liposuction performed under local 
anesthesia at an outpatient medical of-
fi ce. Our aim was to determine wheth-
er other cases of atypical mycobaterial 
infections had previously occurred af-
ter liposuction. M. chelonae is widely 
distributed in soil and water, includ-
ing tap water. Atypical mycobacterial 
infections have been associated with 
skin and soft tissue infections, includ-
ing infections after cosmetic surgeries, 
and outbreaks have been documented 
(1–4). Previously reported potential 
sources of liposuction equipment 
contamination have been inadequate 
disinfection or sterilization after rins-
ing of liposuction equipment with tap 
water, tap water used in cleaning li-
posuction cannulae, or the quaternary 
ammonium solution used to disinfect 
liposuction equipment (2,4). Increased 
numbers of procedures performed in 
freestanding medical centers (not con-
nected with hospitals) that are not rou-
tinely monitored by infection control 
committees or equivalent oversight 
bodies may contribute to atypical my-
cobacterial infection (1).
Our investigation showed that 
proper cleaning, disinfection, and 
sterilization of liposuction equipment 
and other infection control issues at 
this medical offi ce were concerns. 
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Except for the physician, only unli-
censed medical assistants worked at 
this offi ce. This staff had been trained 
to clean and sterilize liposuction 
equipment, but no written procedures 
existed for processing reusable lipo-
suction equipment, no logs were kept 
of autoclave use for sterilization, and 
preventive maintenance checks and 
verifi cation of sterility on the auto-
clave by using biological indicators 
as recommended by the manufacturer 
were not performed. The offi ce did 
not have any general written infection 
control policies. Offi ce staff mixed 
leftover solutions from open small 
bottles of povidone iodine and placed 
this mixture into larger containers. 
Staff stored wet alcohol-soaked cotton 
balls in multiuse containers for wiping 
tops of multidose vials instead of us-
ing individual alcohol prep pads; and 
70% isopropyl alcohol solution from 
an open nonsterile bottle was used in-
stead of sterile irrigation solutions to 
fl ush the liposuction suction cannula 
to dislodge tissue from the ports dur-
ing the procedure.
Case fi nding and surveillance of 
acid-fast bacilli results routinely re-
ported to our public health tuberculo-
sis program did not indicate any other 
cases of postliposuction wound infec-
tions caused by atypical mycobacteria 
associated with this offi ce. Laboratory 
testing of environmental samples, in-
cluding tap water and faucet aerator 
samples, also did not indicate a source 
for M. chelonae in this outpatient of-
fi ce. This case was likely an isolated 
occurrence in which the case-patient 
acquired infection through an environ-
mental source unrelated to this offi ce. 
However, because of the infection 
control concerns observed in this of-
fi ce and because the incubation period 
for M. chelonae can be as long as 5 
months (2), the physician was advised 
to develop infection control policies 
and procedures; develop protocols for 
cleaning, disinfecting, and sterilizing 
liposuction equipment in accordance 
with the manufacturer’s recommen-
dations; ensure autoclave sterility 
by using biological indicators; edu-
cate offi ce staff about basic infection 
control practices and use of aseptic 
techniques; and notify public health 
offi cials of any further infections post-
liposuction.
Risk factors that cause or contrib-
ute to infectious disease outbreaks in 
outpatient settings include inadequate 
cleaning, disinfection, sterilization, 
and storage of instruments and equip-
ment; inappropriate use of barrier 
equipment, such as gloves, by health-
care personnel; inadequate handwash-
ing practices by healthcare workers; 
failure to use aseptic techniques; and 
lack of familiarity with established 
infection control practices by ambu-
latory care personnel (5). Also, in the 
outpatient setting, responsibility for 
implementing an infection control 
program usually is not assigned to a 
specifi c person (5), and outpatient 
medical offi ces are not routinely mon-
itored by oversight bodies or infection 
control committees as are hospitals 
and outpatient surgical centers (6).
The California Business and Pro-
fessions Code requires that outpatient 
surgery settings using anesthesia, 
other than local anesthesia or periph-
eral nerve blocks, be accredited by 
an oversight body. However, because 
this facility used only local anesthe-
sia, it did not fall under this code of 
regulations for facility accreditation, 
oversight, certifi cation standards, and 
quality assurance for general public 
health safety and welfare. 
Lack of adherence to basic infec-
tion control principles, specifi cally 
in outpatient settings, has resulted in 
outbreaks (1,7–10). Our fi ndings at 
this medical offi ce further highlight 
the unaddressed infection control 
problems in outpatient settings. Be-
cause of insuffi cient oversight for the 
outpatient setting, professional orga-
nizations, state medical boards, and 
federal and state authorities should 
consider the need to systematically ad-
dress infection control standards and 
monitoring tailored for this setting. As 
more healthcare procedures move to 
the outpatient setting, ensuring appro-
priate infection control practices can 
prevent outbreaks.
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Infl uenza A 
Pandemic (H1N1) 
2009 Virus and HIV
To the Editor: The effects of in-
fl uenza A pandemic (H1N1) 2009 vi-
rus infection in HIV-infected patients 
are unknown. We describe an HIV-
infected patient with severe pandemic 
(H1N1) 2009 virus infection.
The patient was a 37-year-old, 
HIV-positive, former intravenous drug 
user in a methadone-substitution pro-
gram. She had a history of smoking, 
hepatitis C, and mild chronic obstruc-
tive pulmonary disease not requir-
ing treatment. Since 2007 her viral 
load had been <50 HIV RNA copies/
mL, for which she received tenofovir, 
emtricitabine, and lopinavir/ritonavir. 
Her CD4 count in March 2009 was 
542 cells/μL (25%).
On June 24, 2009, the patient 
entered the Hospital Universitario La 
Paz after 3 days of dyspnea and fever, 
without cough or sputum. Temperature 
was 39°C, blood pressure 118/74 mm 
Hg, pulse rate 110 beats per minute, 
respiratory rate 30 breaths per minute, 
and oxygen saturation 85% on room 
air (fraction of inspired oxygen [FiO2] 
21%).  Lung wheezes were audible. 
Laboratory testing showed leukocyto-
sis with neutrophilia and oxygen par-
tial pressure (pO2) 70.9 mm Hg (FiO2 
21%). Chest radiograph fi ndings were 
consistent with bacterial pneumonia 
(Figure, panel A). Empirical treatment 
with clarithromycin and ceftriaxone 
was started. After full clinical recov-
ery, the patient was discharged on June 
30 and prescribed oral clarithromycin 
and cefi xime.
At a routine follow-up visit on 
July 2, the woman was asymptomatic 
and had fewer leukocytes and neutro-
phils, creatine kinase 800 U/L (refer-
ence <145), and lactate dehydrogenase 
373 U/L (reference <247). On July 3, 
she returned to the hospital because 
of dyspnea and high fever (38.5°C). 
Oxygen saturation was 75%, pO2 33.8 
mm Hg (FiO2 21%), and blood pres-
sure 90/54 mm Hg. Chest radiographs 
showed alveolar infi ltrates in the right 
lower lobe (Figure, panel B). Because 
her deterioration was attributed to 
nosocomial infection, she was given 
meropenem, linezolid, and levofl oxa-
cine and was hospitalized. Within the 
next 96 hours, her condition deteriorat-
ed further to drowsiness, hypotension, 
oxygen saturation 92%, pO2 60.5 mm 
Hg (FiO2 50%), and new radiographic 
bilateral alveolo-interstitial infi ltrates 
appeared (Figure, panel C).
On July 7, real-time reverse tran-
scription–PCR of a nasopharyngeal 
swab confi rmed infl uenza A pandemic 
(H1N1) 2009 virus (1). Other infec-
tious causes for bacterial and viral 
pneumonia were excluded. The pa-
tient received mechanical ventilation 
for 7 days and oseltamivir. She was 
discharged after 21 days. She still had 
dyspnea after exertion and radiologic 
sequelae on chest radiograph (Figure, 
panel D).
No patients or healthcare workers 
who had had contact with the patient 
had confi rmed pandemic (H1N1) 2009 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 7, July 2010 1175 
Figure. Chest radiographs of 37-year-old, HIV-positive woman with severe pandemic 
(H1N1) 2009 virus infection, 2009. A) June 24, alveolar infi ltrate in the right lower lobe. 
B) July 3, minimal pleural effusion, alveolar infi ltrate on right lower lobe, and possibly left 
lower lobe infi ltrate. C) July 6, bilateral alveolo-intertitial infi ltrates. D) July 29, bilateral 
peribroncovascular thickening with fi bro-cicatricial changes; conserved lung volumes.
